Patent · US Active

Soluble C5aR antagonists

US11254695B2 · kind B2 · utility

1Cited by
10References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2019
Grant dateFeb 22, 2022
Priority date—
Expiry dateOct 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/59
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.